Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02AIH
|
|||
| Former ID |
DNC013507
|
|||
| Drug Name |
1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one
|
|||
| Synonyms |
CHEMBL174951; 1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one; SCHEMBL3194478; BDBM50163189
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H14N2O2
|
|||
| Canonical SMILES |
CCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2
|
|||
| InChI |
1S/C13H14N2O2/c1-2-3-7-11(16)13-15-9-12(17-13)10-6-4-5-8-14-10/h4-6,8-9H,2-3,7H2,1H3
|
|||
| InChIKey |
ZGJFSRIJAXSNIH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.